PACB

Pacific Biosciences of California, Inc. | Cotação de Ações

Última atualização23/12/2024, 13:26:09

PreçoUS$ 1,93

Variação (dia)-US$ 0,05 (-2.28%)▼

Min. 52 SemanasUS$ 1,16

Máx. 52 SemanasUS$ 10,65

Capitalização de mercado--

Endereço: 1305 O’Brien Drive, Menlo Park, CA, 94025

Telefone: 650 521 8000

Funcionários: 796

Pacific Biosciences of CalifornPACB

US$ 1,93

- 0,0452,3%

23/12/2024 13:26:09

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atualUS$ 1,93

Valor de mercado--

AberturaUS$ 2,10

Preço máximoUS$ 2,04

Preço mínimoUS$ 1,87

VolumeUS$ 1,7 mi

Fechamento anteriorUS$ 1,97

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Ações relacionadas

Twist Bioscience Corporation

TWST ▼0.33% | US$ 47,62

Intellia Therapeutics, Inc.

NTLA ▼0.14% | US$ 12,05

Editas Medicine, Inc.

EDIT ▼0.04% | US$ 1,27

CRISPR Therapeutics AG

CRSP ▼0.43% | US$ 40,29

Beam Therapeutics Inc.

BEAM ▼0.33% | US$ 28,68

Fique por dentro das últimas notícias do mundo financeiro em nosso Blog

Mantenha-se atualizado com as últimas notícias financeiras em nosso Blog. Publicamos artigos informativos e análises de especialistas para fornecer insights valiosos sobre o cenário financeiro em constante evolução.

Explore os ativos do mercado financeiro em tempo real com a nossa API

A API da brapi proporciona uma visão dos ativos do mercado financeiro. Com gráficos interativos e dados atualizados, oferecemos uma análise abrangente das tendências do mercado. Os desenvolvedores podem personalizar os módulos, configurar o range de tempo e escolher todos os dados necessários para decisões informadas.

Assine nossa newsletter para receber atualizações gratuitas por e-mail

Mantenha-se informado assinando nossa newsletter. Receba atualizações gratuitas por e-mail, incluindo rendimentos, novidades do mercado e insights valiosos. Estamos comprometidos em fornecer informações relevantes diretamente à sua caixa de entrada.